loader image
Sunday, February 23, 2025
46.3 F
McAllen
We Welcome your Press Release
- Advertisement -

UTPA is hosting three conferences this week that discuss health care issues

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

On Wednesday, March 26, UTPA’s Bioethics Research Conference will host several panels that discuss the ethical implications to many medical and health issues, including: “Keeping People Alive Against Their Will in Texas: Examining Cases Like Marlise Muñoz” and “Are Celebrities Killing Us? The Vaccination Scare and the Impact of Celebrities on Public Health.”

On Thursday, March 27, The College of Social and Behavioral Sciences will host its Eighth Annual Research Conference . This year’s focus is Health and Health Policy in the Social Sciences.

On Friday, March 28, The College of Health Sciences and Human Services will host its Second Annual MORE Health @UTPA, which will have presentations on medical research. MORE Health will conclude with a community health fair Saturday, March 29 at the UTPA Ballroom where participants can receive free health screenings and other services.

- Advertisement -

Below, please find a link to the agendas for the conferences.  Thank you all for your continued support of UTPA.

https://www.utpa.edu/features/more-health/

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×